Text size
Menu
Home / Education & Practice Supports/ Clinical Tools & Resources

Filter

Filters
Publication date
Last Updated
Showing 1 - 8 of 8
SORT:

Self-monitoring blood glucose (SMBG)

Type:

Clinical Tool

Source:

Canadian Diabetes Association

Want to know how often a patient should be checking their blood glucose levels?

 

The Canadian Diabetes Association (CDA) created a tool that suggests monitoring frequency for a patient to monitor their blood glucose levels. Use this tool to ensure your recommendations align with accurate blood glucose monitoring practices.

Tags: Endocrinology and Metabolism

Diabetes Canada CPGs

Type:

Guideline

Source:

Diabetes Canada

Looking for a comprehensive resource for diabetes care?

 

The Canadian Diabetes Association created the 2018 Clinical Practice Guidelines to support clinicians with the management of patients with diabetes. Refer to these resources as a first stop when you have questions about type 1 or 2 diabetes care.

Tags: Endocrinology and Metabolism

Insulin Prescription Tool

Type:

Clinical Tool

Source:

Diabetes Canada

Want a reference around insulin prescribing?

 

The Canadian Diabetes Association created this template to support clinicians with prescribing insulin products. Refer to this resource if you need a refresher on prescribing insulin products.

Tags: Endocrinology and Metabolism, Medication Management

#295 Mission Slimpossible: Semaglutide for weight loss

Type:

PEER Tools for Practice

Source:

PEER Tools for Practice

Have patients asking for semaglutide (Ozempic®) for weight loss?

 

This PEER Tool for Practice provides the latest evidence on semaglutide (Ozempic®) for weight loss. Refer to this article if you need support for conversations around pharmacological treatment for weight loss.

Tags: Endocrinology and Metabolism

#311 “Ultralong”-acting insulin for diabetes: How long is long enough?

Type:

PEER Tools for Practice

Source:

PEER Tools for Practice

How long does degludec insulin last compared to long-acting or NPH insulin?

 

This PEER Tool for Practice presents evidence from five systematic reviews that compared degludec to glargine in individuals with type 1 diabetes and type 2 diabetes, and found there is reduced risk of severe hypoglycemia with degludec. Symptomatic hypoglycemia is either similar or lower with degludec, and there were no other differences in clinical outcomes or hemoglobin A1c.

Tags: Endocrinology and Metabolism

#312 Thirsty for weight loss ideas? Water for weight loss

Type:

PEER Tools for Practice

Source:

PEER Tools for Practice

Does increasing water lead to meaningful weight loss?

 

This PEER Tool for Practice summarizes the evidence for whether increased water consumption has any effect on weight loss.

Tags: Endocrinology and Metabolism, Nutrition

#314 Weight to Go: Naltrexone/bupropion for weight loss

Type:

PEER Tools for Practice

Source:

PEER Tools for Practice

Is naltrexone/bupropion (Contrave®) effective for weight loss?

 

This PEER Tool for Practice provides the latest evidence on naltrexone/bupropion (Contrave®) for weight loss. Refer to this article if you need support for conversations around pharmacological treatment for weight loss.

Tags: Endocrinology and Metabolism

#319 Should a ‘flozin’ be chosen? Part 2: SGLT2 inhibitors in patients with chronic kidney disease

Type:

PEER Tools for Practice

Source:

PEER Tools for Practice

Wondering if sodium-glucose cotransporter 2 inhibitors (SGLT2i) have any effect on patient-relevant outcomes in chronic kidney disease (CKD)?

 

This PEER Tool for Practice examines the evidence for SGLT2i treatment in patients with CKD. Read this article to see the impact of SGLT2 inhibitors in CKD.

Tags: Endocrinology and Metabolism, Nephrology, Urology